INTRODUCTION
Cannabis withdrawal is recognised as a consequence of cannabis dependence following the cessation of use. 1 The symptoms include irritability, anger or aggression; nervousness or anxiety; insomnia; decreased appetite or weight loss; restlessness; depressed mood; and physical symptoms, for example,
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headache and sweating. Symptoms typically begin within 24 h of cessation, persisting for up to 28 days. 2 3 Cannabis withdrawal syndrome is proposed for inclusion in the next Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5). 4 Of particular clinical importance, withdrawal contributes to difficulties abstaining from cannabis 5 and increases the likelihood of relapse in order to relieve withdrawal distress. 6 7 The proposed DSM-5 cannabis withdrawal syndrome criteria are informed by studies conducted mainly in treatmentseeking groups and adolescents, 1 in whom higher rates of use and cannabis-related problems have been documented. 2 4 5 No known published studies have specifically targeted ethnic minorities or marginalised subpopulations such as the First Nations and Indigenous peoples of North America or Australasia.
This study focuses on Indigenous Australians in one part of northern Australia, where the levels of cannabis use are very high. While cannabis use in Australia's general population may have been declining, 8 the impacts of endemic cannabis use in remote Indigenous Australian communities are increasingly evident. 9 Australian government surveys report past-year cannabis use for Indigenous Australians of 16% compared to 10% of the general population. 8 Studies in remote communities in Australia's Arnhem Land, Northern Territory 10 and Cape York, far north Queensland, 11 have documented very high rates, up to 66% (in those aged 13-36 years), with a reported rapid rise in cannabis use in the late 1990s. 10 Cannabis use is associated with criminal behaviours and incarceration. 12 Unpublished pilot data were collected from 101 males incarcerated for 2 years or less in a far north Queensland correctional centre including 69% who were self-reported current cannabis users before incarceration: 70% recalling three or more symptoms of cannabis withdrawal during the week following their arrest. 13 Participants also described 'stressing out' characterised by aggression, intimidation and anxiousness, contributing to disrupting family/relationships 5 when cannabis was not available in their home community. 'Stressing out' may be a phenomenon similar to, if not the same as, cannabis withdrawal.
Indigenous Australians are incarcerated 15 times more frequently than the general population, 14 with a rapidly increasing rate of incarceration for females of great concern. 15 Higher rates of cannabis use are found in prison inmates and expectation of post-release drug use is a significant predictor of reincarceration. 16 This project explores the nature and prevalence of the cannabis withdrawal syndrome and its measurement among individuals immediately following incarceration. The findings will enhance screening in prisons and similar environments and provide approaches to develop targeted interventions for cannabis withdrawal. The tightly controlled conditions of enforced abstinence in prison inmates close to entry into custody furnish a rare opportunity to understand cannabis withdrawal and the experience of 'stressing out' as well as an opportunity to address an unmet need for support in this highly marginalised and disadvantaged group.
The study objectives are to 
METHODS AND ANALYSIS Study overview
This study design is in line with the first and second phases in the schema of Campbell et al, 17 for the design and implementation of complex interventions to improve health: 'modelling or identifying components of an intervention which are likely to work' and an 'exploratory trial of components'.
While Western views and assessment of mental health and ill health typically focus on personal experience, indigenous concepts of mental health are often more holistic and consider spirituality, environment, family and community in addition to personal experiences. 18 Considering this, symptom assessment methodologies for cannabis withdrawal will be validated to ensure cultural relevance. Aspects of cultural equivalence will be explored systematically using both qualitative and quantitative measures. 19 To accomplish the first objective, the validated CWS 20 21 will be administered together with a semistructured interview to explore patterns and experiences of cannabis use. The themes in the data will assist to better understand symptoms and how they are experienced by inmates during initial incarceration when cannabis use is curtailed. Themes and symptoms will be considered by an expert reference group and cultural informants to develop a modified CWS, (I-CWS) for piloting.
For the second objective, new prisoners, within 1 week of incarceration, will undergo examination for symptomology and severity of cannabis withdrawal using a battery of scales, including the modified I-CWS measured on eight occasions over 28 days (figure 1).
The third and fourth objectives involve a series of focus groups comprised of prison inmates and prison staff. Semistructured interviews will be used to develop the I-CWS (Objective 1); the cannabis withdrawal assessments of new prison inmates (Objective 2) will be used to refine it during the first 12 months. The resource development phase (Objective 3) will overlap with interviews and assessments. The resource dissemination and evaluation phases (Objectives 3 and 4) will start by the 18th month and will be completed by the end of the 21st month. The design allows 24 months for interviews, assessments, focus groups, data analysis, research feedback and reporting (figure 2). A process evaluation will be undertaken over the course of the project.
Setting
Data will be collected using interviews with prisoners in three custodial localities in north Queensland-a watch house run by the Queensland Police Service (QPS) and two correctional centres run by Queensland Department of Corrections (QCS). North Queensland correctional centres report that 65-80% of prison inmates identify as Indigenous Australian, many of whom are from communities in Cape York and Torres Strait regions in far north Queensland.
Cape York covers 12 statistical regions, ∼128 000 km 2 (7.4% of the total area of Queensland) with a population of approximately 7800 Indigenous Australians. 22 The Torres Strait Islands is a cluster of over 250 islands ∼1380 km 2 (0.1% of the total area of Queensland) with a population of approximately 5900 Indigenous Australians. 23 Specific methodological and ethical considerations arise in conducting research in a prison or detention environment. 24 Involving prisoners as cultural informants to guide the recruitment process may assist to minimise the prospect that prisoners will feel coerced or that there is undue inducement or obligation to speak to a researcher. Additional measures must ensure that recruitment does not lead to any misapprehension of possible benefit including sentence reduction or help with parole. 25 Participant selection and recruitment Participant selection will occur in three stages outlined in figure 3 . Firstly, to validate the I-CWS (Objective 1), participants will be prisoners who have been in custody for 2-24 months, be 18-40 years, Indigenous (Aboriginal and/or Torres Strait Islander) and will have tried cannabis at least once in the 12 months preceding incarceration to ensure variance in former levels of use and dependence. For Objective 2, participants will be new prisoners, 18-40 years, Indigenous, heavy cannabis users (five or more days use on an average over the 3 months before prison), cannabis dependent and available to complete withdrawal symptom assessments on eight occasions over 28 days. Initial assessment will start at the QPS watch house and will be completed while in prison. To recognise cultural differences between Aboriginal and Torres Strait Islanders, Objective 3 will be achieved by inviting prison inmates to join one of two focus (F) groups-Aboriginal (F1) and Torres Strait Islanders (F2). A third focus group (F3) will consist of QCS prison officers with at least 6 months service. Focus groups will guide the content and parameters of resource development to manage withdrawal, which will be disseminated before evaluating their utility and uptake (Objective 4).
Potential participants will be excluded if there are confounding health/mental health issues or if the participant is deemed unsuitable for interview by QCS staff. For each objective, the exclusion criteria are Objectives 1, 3 and 4: those aged <18 and >40 years. Objective 2: those aged <18 and >40 years, who are alcohol or other drug dependent (using National Health and Medical Research Council (NHMRC) guidelines 26 and/or DSM dependence criteria and previously undergone any drug treatment, detoxification or rehabilitation.
Notices asking for volunteers to participate in the study will be placed within the correctional centres. To ascertain the eligibility for Objective 2, upon reception to the police watch house, QPS officers will notify researchers of those who are identified as Indigenous and who are aged between 18 and 40 years. Researchers will meet the detainee to provide an information sheet and explain the study purpose and design, voluntary participation and procedures for withdrawing from the study. Written informed consent will be obtained from those who wish to participate and a full eligibility assessment undertaken. Participants will be compensated $5 for each assessment completed (total $40 if all assessments completed) with the payment made to their institutional account. Paying prison inmates for participation is a matter of some controversy, but is common in criminological research. 27 The initial battery of scales will be administered taking approximately 40 min, with subsequent assessments requiring between 10 and 30 min (figure 1).
Sample size calculation Qualitative A purposive sample of 20 Indigenous prison inmates and 10 QCS prison officers will be invited to join one of three focus groups. Qualitative studies usually have smaller sample sizes of 10-20 deemed suitable to achieve data saturation. 28 Quantitative Pilot data 13 provided estimates of the potential sample pool with 79% of prisoners being identified as Indigenous, 69% as cannabis users and 84% who had experienced one or more withdrawal symptoms before incarceration. The sample pool will be 314 males (based on 750 new prison inmates estimated over study period) and 156 females (with an estimated 330 new prison inmates over study period).
A sample size of 60 men and 60 women is a practical and achievable target with the resources available. With the prevalence of withdrawal symptoms, expected from pilot data to be approximately 70%, a precision of 0.264 can be achieved (95% CI 0.568 to 0.812). These sample sizes provide study power in excess of 80% to detect differences between the eight repeated measures from baseline to 28 days (significance of 0.05) enabling a time series analysis of symptom score to be adjusted for three characteristics with one degree of freedom and still maintaining a stable model. 29 
MEASURES/DATA COLLECTION Questionnaire adaptation
An interactive and conversational approach, 'research yarning', 30 is congruent with local and regional cultural processes. Questionnaires will be developed with focus groups and cultural informants using this approach to ensure appropriate wording/language, placement and cultural context. Qualitative data will be collected during this adaptation phase to ensure compatibility with cultural context and, once the questionnaires have been revised, a test-retest will be undertaken to ensure reliability.
Information collection
A series of open-ended questions will be used in the eligibility assessments to build rapport and to determine whether inclusion criteria are met. The timeline follow back method 31 will be used at the eligibility interview to assess each participant's use of cannabis and other substances before incarceration, withdrawal symptoms, impact on family, finances and community, quitting intentions/attempts, understanding of withdrawal/'stressing out' and if any strategies were used to manage withdrawal.
Both qualitative and quantitative data will be collected during this phase. Participants will be asked their age, living arrangements before incarceration, education and work history. 
Quantitative measures
We will assess the participants at baseline and on days 1, 3, 5, 7, 10, 14 and 28 following initial detention (figure 1). Alcohol, cannabis and other drug use will be measured using the Alcohol, Smoking and Substance Involvement Screening Test, 32 with cannabis dependence measured at baseline and again at 28 days, using the Severity of Dependence Scale. 33 As not all measures are validated for use with Indigenous prison inmates, structured clinical interviews 34 will assess dependence, presence of mood episodes/disorders, psychotic and anxiety and adjustment disorders along with possible other drug dependence. To account for and monitor stresses experienced early in incarceration, psychological distress will be measured at baseline and subsequently on seven occasions using the modified Kessler 6 Psychological Distress Scale (K6), which has been used previously in Indigenous populations. 35 Salivary cortisol levels, a non-intrusive objective marker of stress, 36 will be assessed on the same days as psychological distress using the K6. The eight I-CWS assessments will be used to validate the CWS ( figure 1 ).
This schedule is feasible within the routine of prison programming with 960 assessments (60 male and 60 female participants × 8 occasions) to be conducted overall. At day 28, when withdrawal symptoms are likely to have subsided, 37 a further assessment of dependence and an in-depth interview will also be conducted to explore qualitative experiences of withdrawal.
The research will be guided by experts in substance misuse and treatment including Indigenous cultural advisors, by cultural officers employed by QCS. Cultural informant groups, consisting of prison inmates at each site, will be formed through several group discussions. All groups will guide the development of the I-CWS to examine the validity of the symptoms and understanding of withdrawal and 'stressing out'. The groups will also provide input to the format of the I-CWS with regard to pictorial representation and the phrasing and wording of the symptom description.
Process measures
Resources aimed at enabling new prison inmates to recognise and manage symptoms of cannabis withdrawal will be developed and assessed within an action research framework, guided by the expert reference group, Indigenous advisors and cultural informants. These resources will be piloted with new prison inmates prior to dissemination for use by prison staff, as far as it is practicable. 38 Because of the national importance of reducing rates of incarceration in Indigenous people, 39 the procedures used to engage QCS in embedding the resources into current practice will be described. We will record, via an implementation log completed by prison staff, the extent to which these resources are provided to, and used by, the prison inmate population.
Acceptability and feasibility will be determined by the administration of an additional questionnaire/interview at focus group meetings 4, 5 and 6 (figure 2), the expert reference group, Indigenous advisors and cultural informants.
PROPOSED INTERVENTIONS
Treatments for cannabis withdrawal are only beginning to be investigated with no evidence-based interventions available for Indigenous populations. Currently, there is very little support for the treatment of cannabis-related problems for Indigenous populations, incarcerated or not. Managing withdrawal symptoms currently focuses on information provision and psychosocial interventions (eg, counselling and sleep management). 40 41 The complex relationship between drug use and criminal behaviour, with differences occurring between men and women, requires any treatment or intervention to target specific personal drug use and mental health histories. Factors common to drug use and crime (eg, sexual/ physical abuse, mental health problems, family problems) should be identified and treated concurrently. 42 The focus groups will guide the development of the interventions and may range from brief interventions to stepped care models, based on psychosocial or social cognition therapies. Frameworks to be considered include psychoeducation, motivational enhancement, cognitive behaviour-based therapies, 9 family and social emotional well-being 43 and/or social cognition training. 44 It is intended that interventions will focus on continuing rehabilitation after release to assist with reintegration and management to reduce the risk relapse.
Intervention components will be developed in consultation with the focus groups to ensure cultural relevance and to align with best practice frameworks, so that they are practical, appropriate for the average level of cognitive function evident among prison inmates and address the identified needs for treatment. 45 
ANALYSIS OF DATA Qualitative analysis
For Objective 1, themes described and symptoms experienced during initial incarceration and when cannabis use is curtailed will be documented. Using a simplified Delphi technique, already applied in Indigenous mental health research, 46 themes and symptoms will be considered by the expert reference group and mapped against the CWS. Themes and symptoms will be provided to the expert reference group blinded and conducted in rounds until consensus is obtained.
To achieve the third and fourth objectives, qualitative information will be transcribed and analysed by two researchers. Sampling will continue until data are saturated with no new themes or categories emerging from the data. NVIVO software enables multilevel coding of text against a set of predetermined analytical categories. The research team will use an iterative process to understand the themes and key issues arising from the data, which will be coded independently with divergent views reconciled by a third researcher.
Statistical analysis and data management
To accomplish Objective 2, generalised estimating equations will be used to analyse Indigenous I-CWS scores over time. 47 Modelling will test influences of time in abstinence from cannabis on total daily withdrawal scores (dependent variable) summed across all valid items in the Indigenous I-CWS. Demographic and other characteristics will be examined for their role in influencing scores over time.
Statistical analysis of quantitative data will be performed using IBM PASW SPSS software V.20.0 (IBM SPSS, Chicago, Illinois, USA) and analysis of qualitative data supported by QSR NVIVO V.10.
LIMITATIONS
Illicit drug use is a stigmatised and sensitive topic which may hinder recruitment and retention of participants. In addition, the study must fit within the tight schedules and local procedures at the three sites run by QPS and QCS. The study includes only two prison sites within Queensland and generalisations must be made with caution. However, this research is made possible by sound local relationships of trust with prison inmates with advice sought from the prison inmate reference group as cultural informants, enhancing its transferability. Protocols within the QPS watch house and QCS correctional centres will be adhered to at all times. The limited available resources prevent a larger scale multisite study.
There are risks associated with participation in this research which could implicate participants in further criminal charges if incriminating information is disclosed. Participants will be informed of this risk before involvement in the study and of the right to withdraw at any stage. A risk-management strategy 24 proposes that matters of high risk and of intrinsic interest to law enforcement would be avoided in the study, that is, supply and distribution networks and participants' roles in them, matters related to other crimes not heard before a court or under investigation and/or matters related to any future planned crimes.
Confounding variables such as stress related to incarceration, withdrawal from tobacco and other substance use and pre-existing or undiagnosed mental health issues may impact the results.
RELEVANCE
There is a dearth of research pertaining to cannabis withdrawal in Indigenous populations, arguably the most at-risk populations for cannabis-related harms in Australia owing to endemic levels of use with associated mental health issues. Indigenous Australians are four to five times more likely than non-Indigenous Australians to be hospitalised for mental or behavioural disorders owing to the use of psychoactive substance. 48 In remote communities in the Cape York region of far north Queensland, endemic cannabis has been linked to psychosis which is believed to play a role in the onset of illness in 61% of men and 37% of women (aged ≥15 year). 49 Studies with the potential for therapeutic outcome comprise a small proportion of published prisoner research. 39 In the USA, and mirrored in Australia, prisoners released to liberty are returning to their communities with a plethora of unaddressed health issues, particularly mental health and substance abuse problems. 50 51 Resources developed will assist new prison inmates to manage cannabis withdrawal and may assist communities to manage 'stressing out', widely observed and reported when cannabis is not available.
Of considerable importance, the results of this study will provide information about the onset, time-course and severity of withdrawal of populations in a nontreatment study population, the focus of few cannabis withdrawal studies. Custodial settings provide a controlled environment that addresses many of the methodological issues of previous studies where participant recruitment, drop out and abstinence has been problematic.
The strength of this research team is its capacity to translate the practical outcomes of the study to the development of sustainable, easily delivered resources to better manage mental health, withdrawal and cannabis-related issues in newly incarcerated Indigenous prison inmates.
ETHICS AND DISSEMINATION
The James Cook University ( JCU) Human Research Ethics Committee has approved the proposal for the study H4651, as well as related information sheets and consent forms summarising the research and roles of potential participants. All project data will be deidentified by removing the statements identifying participants prior to their use in published materials. All questionnaire, interview and focus group data will be stored securely in password-protected folders accessible only to the research team. In accordance with Australia's NHMRC guidelines, 52 all project data will be retained for a minimum of 7 years. Participants will be provided with contact details of the research team to enable them to address any potential queries or concerns. Any complaints will be systematically recorded and acted upon in accordance with JCU guidelines. Participants will be informed of their right to access their own results, and the overall results of the research, in accordance with NHMRC guidelines. 51 Journal articles developed from the research will be sent to all project partners for dissemination to participants, and deidentified results provided in progress reports to QCS and QPS. Conference and seminars will be presented to Australian and international healthcare stakeholders, researchers and academics. 
